ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO056

Neutrophil-Gelatinase Associated Lipocalin (NGAL) Attenuates ANCA-Induced Glomerulonephritis by Inhibiting Th17 Immunity

Session Information

Category: Glomerular

  • 1001 Glomerular: Basic/Experimental Immunology and Inflammation

Authors

  • Schreiber, Adrian, Charite Berlin, Berlin, Germany
  • Panzer, Ulf, None, Hamburg, Germany
  • Rousselle, Anthony, ECRC, Berlin, Germany
  • Kettritz, Ralph, Universitatsmedizin Berlin, Berlin, Germany
Background

ANCA activate neutrophils and monocytes and thereby participate in vasculitis and necrotizing crescentic glomerulonephritis (NCGN). NGAL is a marker of intrinsic kidney injury and is expressed by neutrophils and renal tubular cells. Whether or not NGAL is merely a diagnostic marker or participates mechanistically in renal damage is not known. We hypothesized that neutrophil NGAL plays a pathogenic role in ANCA-induced NCGN.

Results

Patients with active ANCA disease demonstrated strongly increased NGAL serum levels by western blot analysis (47.3±13.1 optical density, OD) compared to patients in remission (19.4±8.1OD) and healthy controls (2.1±0.4OD). By ELISA, both PR3-ANCA and MPO-ANCA stimulated NGAL release from human neutrophils (887±72 and 961±70 ng/ml, respectively), whereas control IgG induced much lower levels (105±21ng/ml). In addition, mice with anti-MPO-induced NCGN demonstrated upregulated NGAL serum levels. To assess the role of neutrophil NGAL in vivo, we used a murine model of anti-MPO induced NCGN, where mMPO-immunized MPO-deficient mice were transplanted with either WT- or NGAL-deficient BM. NCGN was significantly aggravated in mice that received NGAL-deficient BM (34.8±6.1% crescents in NGAL-KO versus 13.4±2.8% in WT mice). With respect to intrinsic neutrophil function, migration, ROS generation, degranulation and apoptosis were similar in NGAL-KO and WT neutrophils. In addition, humoral immunity to MPO did not differ between both groups. In contrast, flow cytometry demonstrated significantly increased renal T-cells in NGAL-deficient mice: TH17 cells were 21.7±7.6% of renal CD4 cells versus 5.7±1.0%. Splenocytes from NGAL-deficient mice demonstrated a higher proliferation rate than splenocytes from WT mice. Finally, to assess the specific role of TH17 immunity in anti-MPO-induced NCGN, immunized MPO-KO and MPO-/IL17A-double-KO mice were transplanted with either WT or IL17A-KO BM, respectively. NCGN was significantly attenuated in IL17A-KO mice compared to WT mice as assessed by urine pathology and renal histology (2.5±1.3% crescents in MPO-/IL17A-double-KO versus 29.6±7.2% in MPO-KO mice).

Conclusion

Our findings indicate that neutrophil NGAL down-regulates inflammation in ANCA-induced NCGN by inhibiting TH17 immunity and TH17 cells are clearly necessary for induction of ANCA-mediated NCGN.

Funding

  • Government Support - Non-U.S.